1. Home
  2. FCN vs ALKS Comparison

FCN vs ALKS Comparison

Compare FCN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCN
  • ALKS
  • Stock Information
  • Founded
  • FCN 1982
  • ALKS 1987
  • Country
  • FCN United States
  • ALKS Ireland
  • Employees
  • FCN N/A
  • ALKS N/A
  • Industry
  • FCN Professional Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCN Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • FCN Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • FCN 5.5B
  • ALKS 5.1B
  • IPO Year
  • FCN 1996
  • ALKS 1991
  • Fundamental
  • Price
  • FCN $164.28
  • ALKS $29.05
  • Analyst Decision
  • FCN Hold
  • ALKS Buy
  • Analyst Count
  • FCN 2
  • ALKS 12
  • Target Price
  • FCN $175.50
  • ALKS $40.00
  • AVG Volume (30 Days)
  • FCN 405.6K
  • ALKS 1.7M
  • Earning Date
  • FCN 07-24-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • FCN N/A
  • ALKS N/A
  • EPS Growth
  • FCN N/A
  • ALKS N/A
  • EPS
  • FCN 7.32
  • ALKS 2.09
  • Revenue
  • FCN $3,668,381,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • FCN $0.23
  • ALKS N/A
  • Revenue Next Year
  • FCN $6.96
  • ALKS $4.25
  • P/E Ratio
  • FCN $22.06
  • ALKS $13.86
  • Revenue Growth
  • FCN 1.59
  • ALKS N/A
  • 52 Week Low
  • FCN $151.75
  • ALKS $22.90
  • 52 Week High
  • FCN $243.60
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • FCN 55.26
  • ALKS 40.26
  • Support Level
  • FCN $159.54
  • ALKS $29.26
  • Resistance Level
  • FCN $162.93
  • ALKS $29.53
  • Average True Range (ATR)
  • FCN 2.72
  • ALKS 0.69
  • MACD
  • FCN 0.31
  • ALKS -0.14
  • Stochastic Oscillator
  • FCN 84.29
  • ALKS 14.74

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: